Periprocedural management of hemostatic alterations in patients with cirrhosis and vascular liver disorders: a step forward of the American Association for the Study of Liver Diseases.
作者信息
Fortea José Ignacio, Puente Ángela, Crespo Javier, Fábrega Emilio
机构信息
Gastroenterology and Hepatology Department, Clinical and Translational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Marqués de Valdecilla University Hospital, Santander, Spain.
出版信息
Hepatobiliary Surg Nutr. 2023 Feb 28;12(1):105-109. doi: 10.21037/hbsn-22-556. Epub 2023 Jan 16.
Abstract
摘要
相似文献
1
Periprocedural management of hemostatic alterations in patients with cirrhosis and vascular liver disorders: a step forward of the American Association for the Study of Liver Diseases.肝硬化和肝脏血管疾病患者围手术期止血改变的管理：美国肝病研究协会的一项进展
Hepatobiliary Surg Nutr. 2023 Feb 28;12(1):105-109. doi: 10.21037/hbsn-22-556. Epub 2023 Jan 16.
2
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference.肝硬化患者的止血平衡：共识会议报告
Dig Liver Dis. 2016 May;48(5):455-467. doi: 10.1016/j.dld.2016.02.008. Epub 2016 Feb 27.
3
Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment.肝病中的止血改变：病理生理学、临床后果及治疗综述
Dig Surg. 2007;24(4):250-8. doi: 10.1159/000103655. Epub 2007 Jul 27.
4
Rational hemostatic management in cirrhosis: from old paradigms to new clinical challenges.肝硬化的合理止血管理：从旧观念到新的临床挑战。
Expert Rev Hematol. 2022 Dec;15(12):1031-1044. doi: 10.1080/17474086.2022.2144217. Epub 2022 Nov 9.
5
Coagulation Pathways, Hemostasis, and Thrombosis in Liver Failure.肝功能衰竭中的凝血途径、止血和血栓形成。
Semin Respir Crit Care Med. 2018 Oct;39(5):598-608. doi: 10.1055/s-0038-1673658. Epub 2018 Nov 28.
6
Predicting portal thrombosis in cirrhosis: A prospective study of clinical, ultrasonographic and hemostatic factors.预测肝硬化门静脉血栓形成：临床、超声和止血因素的前瞻性研究。
J Hepatol. 2021 Dec;75(6):1367-1376. doi: 10.1016/j.jhep.2021.07.020. Epub 2021 Jul 30.
7
Rebalanced hemostasis in liver disease: a misunderstood coagulopathy.肝脏疾病中的再平衡止血：一种被误解的凝血障碍。
Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):485-491. doi: 10.1182/hematology.2021000283.
8
[Bleeding and thrombosis – acute complications of liver cirrhosis].[出血与血栓形成——肝硬化的急性并发症]
Lakartidningen. 2016 Mar 15;113:DUHD.
9
Disordered hemostasis in extrahepatic portal hypertension.肝外门静脉高压症中的止血障碍
Hepatology. 1993 Oct;18(4):853-7. doi: 10.1002/hep.1840180416.
10
Hemostasis, bleeding and thrombosis in liver disease.肝病中的止血、出血和血栓形成
J Transl Sci. 2017 May;3(3). doi: 10.15761/JTS.1000182. Epub 2017 Mar 4.
引用本文的文献
1
Safety and Efficacy of Ureteroscopic Treatment for Ureteral and Renal Stones in Patients of Cirrhosis with Coagulopathy: A Multicenter Experience.输尿管镜治疗肝硬化合并凝血功能障碍患者输尿管及肾结石的安全性和有效性：一项多中心经验
Eur Urol Open Sci. 2025 Jun 10;77:39-46. doi: 10.1016/j.euros.2025.05.006. eCollection 2025 Jul.
2
Chinese Expert Consensus for the Management of Thrombocytopenia in Cirrhosis.肝硬化血小板减少症管理的中国专家共识
J Clin Transl Hepatol. 2025 Jun 28;13(6):516-523. doi: 10.14218/JCTH.2025.00105. Epub 2025 Apr 24.
本文引用的文献
1
Preprocedural prophylaxis with blood products in patients with cirrhosis: Results from a survey of the Italian Association for the Study of the Liver (AISF).肝硬化患者的术前血液制品预防：意大利肝脏研究协会（AISF）调查结果。
Dig Liver Dis. 2022 Nov;54(11):1520-1526. doi: 10.1016/j.dld.2022.03.017. Epub 2022 Apr 23.
2
EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis.EASL 临床实践指南：肝硬化患者出血和血栓形成的预防和管理。
J Hepatol. 2022 May;76(5):1151-1184. doi: 10.1016/j.jhep.2021.09.003. Epub 2022 Mar 15.
3
Baveno VII - Renewing consensus in portal hypertension.《巴韦诺 VII 共识：门静脉高压领域的新共识》
J Hepatol. 2022 Apr;76(4):959-974. doi: 10.1016/j.jhep.2021.12.022. Epub 2021 Dec 30.
4
Consensus Statement on Hemostatic Management, Anticoagulation, and Antiplatelet Therapy in Liver Transplantation.肝移植中止血管理、抗凝和抗血小板治疗的共识声明。
Transplantation. 2022 Jun 1;106(6):1123-1131. doi: 10.1097/TP.0000000000004014. Epub 2022 Jan 4.
5
Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH.肝硬化患者异常凝血参数和血小板减少症的围手术期管理：来自 ISTH 的 SSC 的指南。
J Thromb Haemost. 2022 Jan;20(1):39-47. doi: 10.1111/jth.15562. Epub 2021 Nov 8.
6
AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis.美国胃肠病学会肝硬化患者凝血功能障碍管理临床实践指南
Gastroenterology. 2021 Nov;161(5):1615-1627.e1. doi: 10.1053/j.gastro.2021.08.015. Epub 2021 Sep 25.
7
Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases.肝病患者的血管性肝脏疾病、门静脉血栓形成及操作出血：美国肝病研究协会2020年实践指南
Hepatology. 2021 Jan;73(1):366-413. doi: 10.1002/hep.31646. Epub 2021 Jan 20.
8
Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC Subcommittee Control of Anticoagulation.内脏静脉血栓形成的抗凝治疗：国际血栓与止血学会（ISTH）科学标准委员会抗凝控制分委员会
J Thromb Haemost. 2020 Jul;18(7):1562-1568. doi: 10.1111/jth.14836.
9
ACG Clinical Guideline: Disorders of the Hepatic and Mesenteric Circulation.ACG 临床指南：肝脏和肠系膜循环紊乱。
Am J Gastroenterol. 2020 Jan;115(1):18-40. doi: 10.14309/ajg.0000000000000486.
10
Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions-Part II: Recommendations: Endorsed by the Canadian Association for Interventional Radiology and the Cardiovascular and Interventional Radiological Society of Europe.介入放射学会关于接受经皮影像引导介入治疗患者围手术期血栓形成和出血风险管理的共识指南 - 第二部分：建议：得到加拿大介入放射学会以及欧洲心血管和介入放射学会认可
J Vasc Interv Radiol. 2019 Aug;30(8):1168-1184.e1. doi: 10.1016/j.jvir.2019.04.017. Epub 2019 Jun 20.
Zotero 插件